Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1189 of 1,261

  1. US 6500798

    Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators

    The Board of Regents of the University of Texas System · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  2. US 6500108

    Radiation delivery system and method

    The Regents of the University of California · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  3. US 6500987

    Sertraline hydrochloride polymorphs

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  4. US 6500859

    Method for treating atherosclerosis or restenosis using microtubule stabilizing agent

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  5. US 6500834

    Composition and method for treatment of cerebral ischemia

    The Board of Regents of the University of Texas System · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  6. US 6500640

    Nucleic acid molecules encoding modified dorsal tissue affecting factor

    The Regents of the University of California · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired

  7. US 6498189

    Method for induction of L-selectin shedding

    The Regents of the University of New Mexico · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  8. US 6498238

    Glycopeptide antibacterial compounds, compositions containing same and methods of using same

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  9. US 6498181

    Synergistic tumorcidal response induced by histamine

    Maxim Pharmaceuticals, Inc. · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  10. US 6498154

    Cyclic regimens using quinazolinone and benzoxazine derivatives

    Ligand Pharmaceuticals Incorporated · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  11. US 6498178

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  12. US 6497884

    Chimeric vaccine against tick-borne encephalitis virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  13. US 6498148

    Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype

    The Regents of the University of California · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  14. US 6498019

    Lecithin-cholesterol acyltransferase protein

    Takeda Chemical Industries Ltd. · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  15. US 6498008

    Method for detecting swine infertility and respiratory virus

    Regents of the University of Minnesota · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  16. US 6497902

    Ionically crosslinked hydrogels with adjustable gelation time

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  17. US 6497877

    Plasminogen activator as an anti-inflammatory agent

    The Regents of the University of Technology Office of Technology Transfer · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  18. US 6495582

    Isoxazole compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

  19. US 6495581

    Oxyiminoalkanoic acid derivatives

    Takeda Chemical Industries Ltd. · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

  20. US 6495322

    RAIDD, a novel death adaptor molecule

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

  21. US 6495143

    Botulinum neurotoxin vaccine

    The United States of America as represented by the Secretary of the Army · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

  22. US 6495145

    LktA deletion mutant of P. haemolytica

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

  23. US 6495072

    Method for making basis for a dental restoration

    Cicero Dental Systems, B.V. · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

  24. US 6495736

    Compositions and methods for increasing bone mineralization

    Darwin Discovery Limited · Granted Dec 17, 2002 · Expires Dec 12, 2022

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.